Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GNBT Generex -- Ignore unavailable to you. Want to Upgrade?

To: MJ who wrote (292)	10/15/2010 3:47:06 PM
From: Hawkmoon	Respond to of 310

Anna resigned------- About frickin' time.. Now they should sue her for bilking the company out of millions in salaries and condo payments I seem to recall she had the company pay on her behalf. Clawback!!! GNBT has good ideas, patents and research-- But can the new management actually execute? That's the question to be answered. Remember, the BOD is still in place, right? Anna is still on the BOD, right? The CEO take guidance from the BOD, right? The entire BOD should also resign, one by one, to be replaced with more determined leadership. After all, they are the ones that kept Anna in place, rather than demanding her resignation years ago. But Anna's resignation is a good start. Hawk